Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(13)
•••
Comment by Acanadianmanon Apr 22, 2019 2:57pm
70 Views
Post# 29655708

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dr RAza Bokhari CEO FSD PHARMA TD AMERITRADE USA

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dr RAza Bokhari CEO FSD PHARMA TD AMERITRADE USAIf you take the time to read their website it states Once complete, the facility is expected to have over 3,800,000 sq. ft of capacity to support cultivation, processing and related ancillary businesses with production in excess of 400,000 kg of cannabis per year. The facility sits on a 70-acre parcel of land of which 30 acres are currently utilized and 40 acres are available for future development. and they also have leased 105000 sq ft from partner Canarra Biotech.......there's the 4 million........DONE!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities